Valuation AstraZeneca PLC Deutsche Boerse AG

Stocks

Market Closed - Deutsche Boerse AG Other stock markets 10:13:04 2026-07-03 EDT			5-day change	1st Jan Change
169.50 ^EUR	+2.98%		+4.44%	+7.08%

07-03	Nordic stocks in North America, Ericsson fell 1.6%	FW
07-02	UK's FTSE 100 clinches over two-month high on cooling Fed rate hike expectations	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	182,034	209,442	209,268	203,171	287,813	299,408	-	-
Change	-	15.06%	-0.08%	-2.91%	41.66%	4.03%	-	-
Enterprise Value (EV) ¹	206,417	232,365	231,778	227,741	311,187	318,681	311,479	303,510
Change	-	12.57%	-0.25%	-1.74%	36.64%	2.41%	-2.26%	-2.56%
P/E	1,469x	64.1x	35.4x	29.1x	28.4x	24.1x	21.2x	18.3x
PBR	4.24x	5.65x	5.39x	5.02x	5.96x	5.64x	4.9x	4.03x
PEG	-	0x	0.4x	1.6x	0.6x	1.1x	1.6x	1.1x
Capitalization / Revenue	4.87x	4.72x	4.57x	3.76x	4.9x	4.73x	4.47x	4.2x
EV / Revenue	5.52x	5.24x	5.06x	4.21x	5.3x	5.03x	4.65x	4.25x
EV / EBITDA	27.2x	25.2x	17.1x	13.6x	16x	14.1x	12.6x	11.2x
EV / EBIT	20.8x	17.4x	15.9x	13.5x	16.8x	15x	13.3x	11.8x
EV / FCF	42.4x	26.7x	25.8x	22.9x	26.5x	31.8x	23.6x	20.7x
FCF Yield	2.36%	3.75%	3.88%	4.36%	3.78%	3.15%	4.24%	4.82%
Dividend per Share ²	2.87	2.9	2.9	3.1	3.2	3.335	3.521	3.657
Rate of return	2.44%	2.15%	2.15%	2.37%	1.72%	1.73%	1.82%	1.89%
EPS ²	0.08	2.11	3.81	4.5	6.54	8.022	9.105	10.58
Distribution rate	3,588%	137%	76.1%	68.9%	48.9%	41.6%	38.7%	34.6%
Net sales ¹	37,417	44,351	45,811	54,073	58,739	63,327	66,978	71,361
EBITDA ¹	7,586	9,237	13,580	16,691	19,476	22,608	24,627	27,002
EBIT ¹	9,928	13,350	14,534	16,928	18,478	21,224	23,500	25,812
Net income ¹	112	3,288	5,961	7,035	10,225	12,464	13,968	16,000
Net Debt ¹	24,383	22,923	22,510	24,570	23,374	19,272	12,070	4,102
Reference price ²	117.51	135.16	135.02	131.05	185.60	193.04	193.04	193.04
Nbr of stocks (in thousands)	1,549,159	1,549,528	1,549,926	1,550,317	1,550,726	1,550,996	-	-
Announcement Date	2/10/22	2/9/23	2/8/24	2/6/25	2/10/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	35.49x	12.89x	26.26x	0.56%	1,082B
JOHNSON & JOHNSON	28.11x	6.46x	17.57x	2.03%	633B
ABBVIE INC.	32.2x	7.69x	15.73x	2.65%	461B
ROCHE HOLDING AG	18.2x	4.52x	11.11x	2.93%	339B
NOVARTIS AG	22.23x	5.7x	13.76x	2.76%	292B
NOVO NORDISK A/S	14.65x	5.43x	11.14x	3.42%	225B
AMGEN INC.	24.39x	6.45x	11.36x	2.7%	202B
GILEAD SCIENCES, INC.	-46.87x	5.66x	31.47x	2.47%	163B
PFIZER INC.	11.37x	3.03x	7.37x	7.2%	139B
Average	15.53x	6.43x	16.20x	2.97%	393B
Weighted average by Cap.	24.28x	8.10x	18.53x	2.16%